| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |